Screener
Xenetic Biosciences XBIO Q3 2025 earnings
Reported November 12, 2025 · Before market open
Revenue$1.0MBeat by $397.0K
EPS-$0.33Beat by $0.16
Revenue estimate$630.0K
EPS estimate-$0.49
Next report
Nov 6, 2026 (in 2 months)Versus estimates
Revenue
Diluted EPS
Q2 2026-$0.41Q1 2026-$0.20Q4 2025-$0.22Beat by $0.30
Q3 2025-$0.33Beat by $0.16
Q2 2025-$0.45Beat by $0.19Q1 2025-$0.59Beat by $0.13FAQ
- When did Xenetic Biosciences report Q3 2025 earnings?
- Xenetic Biosciences (XBIO) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Xenetic Biosciences's Q3 2025 revenue and EPS?
- Xenetic Biosciences reported revenue of $1.0M and eps of $-0.33 for Q3 2025.
- Did Xenetic Biosciences beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $630.0K by $397.0K. EPS beat the consensus estimate of $-0.49 by $0.16.
- How did Xenetic Biosciences's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 67.2% from $614.2K a year earlier and eps declined 17.9% from $-0.28.
- Where can I find Xenetic Biosciences's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001683168-25-008288) and the 10-Q periodic report (0001683168-25-008259) directly on SEC EDGAR. The filing index links above go to sec.gov.
